ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $461,015 | +77.2% | 25,669 | +114.7% | 0.00% | – |
Q1 2023 | $260,184 | -13.0% | 11,957 | +23.9% | 0.00% | – |
Q4 2022 | $298,961 | +39.7% | 9,647 | +14.8% | 0.00% | – |
Q3 2022 | $214,000 | -72.0% | 8,403 | -77.7% | 0.00% | – |
Q2 2022 | $765,000 | +116.1% | 37,680 | +269.4% | 0.00% | – |
Q4 2021 | $354,000 | +1.1% | 10,200 | -37.4% | 0.00% | – |
Q4 2020 | $350,000 | +23.2% | 16,288 | -15.4% | 0.00% | – |
Q3 2020 | $284,000 | -52.3% | 19,246 | -47.6% | 0.00% | -100.0% |
Q4 2019 | $596,000 | +129.2% | 36,709 | +394.7% | 0.00% | – |
Q3 2019 | $260,000 | +26.8% | 7,421 | +104.2% | 0.00% | – |
Q2 2019 | $205,000 | -76.6% | 3,635 | -58.7% | 0.00% | -100.0% |
Q3 2018 | $877,000 | -4.7% | 8,791 | -0.6% | 0.00% | 0.0% |
Q1 2018 | $920,000 | +140.8% | 8,842 | +133.2% | 0.00% | +100.0% |
Q4 2017 | $382,000 | – | 3,792 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |